FEF

Main information

  • Trade name:
  • FEF LIQ
  • Dosage:
  • 300MG,5MG,5MG,45MG,1.5MG,15MCG
  • Pharmaceutical form:
  • LIQ
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FEF LIQ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

29-6-2017

FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas

FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas

The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

FDA - U.S. Food and Drug Administration

28-8-2017

FERROUS GLUCONATE Tablet [Paddock Laboratories, LLC]

FERROUS GLUCONATE Tablet [Paddock Laboratories, LLC]

Updated Date: Aug 28, 2017 EST

US - DailyMed

9-8-2017

FERROUS GLUCONATE Tablet [Westminster Pharmaceuticals, LLC]

FERROUS GLUCONATE Tablet [Westminster Pharmaceuticals, LLC]

Updated Date: Aug 9, 2017 EST

US - DailyMed